Researchers have created and characterized a novel, three-component cross-coupling reaction that is a 'tremendous leap forward' in developing effective and practical iron-based reactions that could be used to create pharmaceuticals. Unlike palladium, the transition metal catalyst most often used in industry and academic labs, iron is abundant, cheap and relatively nontoxic.